IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 152, Issue 2, 2004, Pages 141-145

  Liu, Shihe ^a   Bo, Lijin ^a   Liu, Xuping ^a   Li, Chengwen ^a   Qin, Shuang ^a   Wang, Jianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD2 ANTIGEN; CD22 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD9 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; IDARUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANAMNESIS; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 14; CLINICAL FEATURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; TRANSLOCATION, GENETIC;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 3242740973     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.11.008     Document Type: Article

References (27)

1. Tamura A., Miura I., Iida S., Yokota S., Horiike S., Nishida K., Fujii H., Nakamura S., Seto M., Ueda R., Taniwaki M. Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma. Cancer Genet Cytogenet. 129:2001;1-9
2. Avet-Loiseau H., Brigaudeau C., Morineau N., Talmant P., Lai J.L., Daviet A., Li J.Y., Praloran V., Rapp M.J., Harousseau J.L., Facon T., Bataille R. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization. Genes Chromosomes Cancer. 24:1999;9-15
3. Avet-Loiseau H., Minvielle S., Mellerin M.P., Magrangeas F., Bataille R. 14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias? Hematol J. 1:2000;292-294
4. Nishida K., Tamura A., Nakazawa N., Ueda Y., Abe T., Matsuda F., Kashima K., Taniwaki M. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood. 90:1997;526-534
5. Taniwaki M., Nishida K., Ueda Y., Misawa S., Nagai M., Tagawa S., Yamagami T., Sugiyama H., Abe M., Fukuhara S. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood. 85:1995;3223-3228
6. Taniwaki M., Matsuda F., Jauch A., Nishida K., Takashima T., Tagawa S., Sugiyama H., Misawa S., Abe T., Kashima K. Detection of 14q32 translocations in B-cell malignancies by in situ hybridization with yeast artificial chromosome clones containing the human IgH gene locus. Blood. 83:1994;2962-2969
7. Bergsagel P.L., Nardini E., Brents L., Chesi M., Kuehl W.M. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc. Curr Top Microbiol Immunol. 224:1997;283-287
8. Avet-Loiseau H., Li J.Y., Facon T., Brigaudeau C., Morineau N., Maloisel F., Rapp M.J., Talmant P., Trimoreau F., Jaccard A., Harousseau J.L., Bataille R. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res. 58:1998;5640-5645
9. Rack K.A., Salomon-Nguyen F., Radford-Weiss I., Gil M.O., Schmitt C., Belanger C., Nusbaum S., Vekemans M., Valensi F., Macintyre E.A. FISH detection of chromosome 14q32/IgH translocations: evaluation in follicular lymphoma. Br J Haematol. 103:1998;495-504
10. Siebert R., Matthiesen P., Harder S., Zhang Y., Borowski A., Zuhlke-Jenisch R., Metzke S., Joos S., Weber-Matthiesen K., Grote W., Schlegelberger B. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood. 91:1998;984-990
11. Liu S., Qin S., Wang J., Liu X.P., Bo L.J. Clinical and cytogenetic analysis of patients with lymphoid malignancies carrying 14q32 abnormality. [in Chinese] Zhonghua Xue Ye Xue Za Zhi. 22:2001;569-572. [Chinese Journal of Hematology]
12. Siebert R., Matthiesen P., Harder S., Zhang Y., Borowski A., Zuhlke-Jenisch R., Plendl H., Metzke S., Joos S., Zucca E., Weber-Matthiesen K., Roggero E., Grote W., Schlegelberger B. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Ann Oncol. 9:1998;519-526
13. Monteil M., Callanan M., Dascalescu C., Sotto J.J., Leroux D. Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-colour interphase fluorescence in situ hybridization. Br J Haematol. 93:1996;656-660
14. Jardin F., Gaulard P., Buchonnet G., Contentin N., Lepretre S., Lenain P., Stamatoullas A., Picquenot J.M., Duval C., Parmentier F., Tilly H., Bastard C. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia. 16:2002;2309-2317
15. Huang J.Z., Sanger W.G., Greiner T.C., Staudt L.M., Weisenburger D.D., Pickering D.L., Lynch J.C., Armitage J.O., Warnke R.A., Alizadeh A.A., Lossos I.S., Levy R., Chan W.C. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood. 99:2002;2285-2290
16. Richelda R., Ronchetti D., Baldini L., Cro L., Viggiano L., Marzella R., Rocchi M., Otsuki T., Lombardi L., Maiolo A.T., Neri A. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood. 90:1997;4062-4070
17. Iida S., Rao P.H., Nallasivam P., Hibshoosh H., Butler M., Louie D.C., Dyomin V., Ohno H., Chaganti R.S., Dalla-Favera R. The t(9;14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood. 88:1996;4110-4117
18. Stern M.H., Zhang F.R., Thomas G., Griscelli C., Aurias A. Molecular characterization of ataxia telangiectasia T cell clones: III. Mapping the 14q32.1 distal breakpoint. Hum Genet. 81:1988;18-22
19. Davey M.P., Bertness V., Nakahara K., Johnson J.P., McBride O.W., Waldmann T.A., Kirsch I.R. Juxtaposition of the T-cell receptor α-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphoblastic leukemia and ataxia-telangiectasia. Proc Natl Acad Sci U S A. 85:1988;9287-9291
20. Mengle-Gaw L., Albertson D.G., Sherrington P.D., Rabbitts T.H. Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. Proc Natl Acad Sci U S A. 85:1988;9171-9175
21. Baer R., Heppell A., Taylor A.M., Rabbitts P.H., Boullier B., Rabbitts T.H. The breakpoint of an inversion of chromosome 14 in a T-cell leukemia: sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis. Proc Natl Acad Sci U S A. 84:1987;9069-9073
22. Wiktor A., Puskorius R., Zubrickas K., Van Dyke D.L. Sequential G-banding and fluorescent in situ hybridization on peripheral blood, bone marrow, and amniotic fluid samples. Am J Med Genet. 79:1988;38-41
23. Zhao L., Hayes K., Glassman A. A simple efficient method of sequential G-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet. 103:1988;62-64
24. Iannuzzi L., Gallagher D.S., Ryan A.M., Di Meo G.P., Womack J.E. Chromosomal localization of omega and trophoblast interferon genes in cattle and river buffalo by sequential R-banding and fluorescent in situ hybridization. Cytogenet Cell Genet. 62:1993;224-227
25. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel
26. Reiter A., Schrappe M., Ludwig W.D. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood. 80:1992;2471-2478
27. Fonseca R., Blood E.A., Oken M.M., Kyle R.A., Dewald G.W., Bailey R.J., Van Wier S.A., Henderson K.J., Hoyer J.D., Harrington D., Kay N.E., Van Ness B., Greipp P.R. Myeloma and the t(11;14)(q13;q32): evidence for a biologically defined unique subset of patients. Blood. 99:2002;3735-3741